HEADER TRANSFERASE 18-JUL-23 8PVP TITLE CRYSTAL STRUCTURE OF HUMAN CASEIN KINASE II SUBUNIT ALPHA (CK2A1) IN TITLE 2 COMPLEX WITH ALLOSTERIC COMPOUND FGJG18 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CK II ALPHA; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A1, CK2A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, CK2, ALLOSTERIC INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.KRAEMER,F.GRECO,J.GERNINGHAUS,S.KNAPP,STRUCTURAL GENOMICS AUTHOR 2 CONSORTIUM (SGC) REVDAT 3 07-AUG-24 8PVP 1 JRNL REVDAT 2 31-JUL-24 8PVP 1 COMPND SOURCE JRNL DBREF REVDAT 2 2 1 SEQADV REVDAT 1 20-SEP-23 8PVP 0 JRNL AUTH F.A.GRECO,A.KRAMER,L.WAHL,L.ELSON,T.A.L.EHRET,J.GERNINGHAUS, JRNL AUTH 2 J.MOCKEL,S.MULLER,T.HANKE,S.KNAPP JRNL TITL SYNTHESIS AND EVALUATION OF CHEMICAL LINCHPINS FOR HIGHLY JRNL TITL 2 SELECTIVE CK2 ALPHA TARGETING. JRNL REF EUR.J.MED.CHEM. V. 276 16672 2024 JRNL REFN ISSN 0223-5234 JRNL PMID 39067440 JRNL DOI 10.1016/J.EJMECH.2024.116672 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH F.A.GRECO,A.KRAMER,L.WAHL,L.ELSON,T.A.L.EHRET,J.GERNINGHAUS, REMARK 1 AUTH 2 J.MOCKEL,S.MULLER,T.HANKE,S.KNAPP REMARK 1 TITL SYNTHESIS AND EVALUATION OF CHEMICAL LINCHPINS FOR HIGHLY REMARK 1 TITL 2 SELECTIVE CK2 ALPHA TARGETING REMARK 1 REF BIORXIV 2024 REMARK 1 REFN ISSN 2692-8205 REMARK 1 DOI 10.1101/2024.05.16.594086 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0352 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 30374 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.223 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1614 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2208 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.74 REMARK 3 BIN R VALUE (WORKING SET) : 0.2770 REMARK 3 BIN FREE R VALUE SET COUNT : 121 REMARK 3 BIN FREE R VALUE : 0.3370 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5336 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 133 REMARK 3 SOLVENT ATOMS : 30 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.29 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.85000 REMARK 3 B22 (A**2) : 0.85000 REMARK 3 B33 (A**2) : -1.71000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.476 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.286 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.214 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.074 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.928 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5608 ; 0.008 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): 4859 ; 0.001 ; 0.016 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7628 ; 1.520 ; 1.652 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11260 ; 0.563 ; 1.588 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 655 ; 6.719 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 37 ; 9.215 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 884 ;16.469 ;10.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 813 ; 0.080 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6623 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1189 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2626 ; 4.512 ; 5.351 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2626 ; 4.509 ; 5.351 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3279 ; 6.822 ; 8.016 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 3280 ; 6.825 ; 8.018 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2982 ; 5.048 ; 5.653 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2935 ; 4.851 ; 5.600 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 4278 ; 7.367 ; 8.286 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 8PVP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-JUL-23. REMARK 100 THE DEPOSITION ID IS D_1292130267. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-OCT-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9999 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32045 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 44.740 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 8.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.72 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIA SULPHATE 0.1 M BIS-TRIS REMARK 280 PH 5.5 23-26% PEG 3350, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.91900 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 63.50450 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 63.50450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 94.37850 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 63.50450 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 63.50450 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 31.45950 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 63.50450 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 63.50450 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 94.37850 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 63.50450 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 63.50450 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 31.45950 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 62.91900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 ALA A 332 REMARK 465 ARG A 333 REMARK 465 MET A 334 REMARK 465 GLY A 335 REMARK 465 SER A 336 REMARK 465 SER A 337 REMARK 465 SER B 0 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 GLY B 3 REMARK 465 ALA B 332 REMARK 465 ARG B 333 REMARK 465 MET B 334 REMARK 465 GLY B 335 REMARK 465 SER B 336 REMARK 465 SER B 337 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 21 NE CZ NH1 NH2 REMARK 470 GLN A 36 CG CD OE1 NE2 REMARK 470 ARG A 47 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 49 CG CD CE NZ REMARK 470 LYS A 64 CG CD CE NZ REMARK 470 LYS A 74 CE NZ REMARK 470 LYS A 75 CG CD CE NZ REMARK 470 LYS A 76 CE NZ REMARK 470 LYS A 77 CD CE NZ REMARK 470 ARG A 107 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 120 CG OD1 OD2 REMARK 470 PHE A 121 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 122 CG CD CE NZ REMARK 470 GLN A 123 CG CD OE1 NE2 REMARK 470 GLN A 126 CG CD OE1 NE2 REMARK 470 VAL A 162 CG1 CG2 REMARK 470 GLU A 167 CG CD OE1 OE2 REMARK 470 ARG A 169 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 170 CG CD CE NZ REMARK 470 GLU A 252 CG CD OE1 OE2 REMARK 470 ARG A 268 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 271 CG OD1 OD2 REMARK 470 ARG A 275 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 283 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 290 CG CD OE1 NE2 REMARK 470 ARG A 316 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 329 CG CD CE NZ REMARK 470 ARG B 21 NE CZ NH1 NH2 REMARK 470 GLU B 32 CG CD OE1 OE2 REMARK 470 GLN B 36 CG CD OE1 NE2 REMARK 470 ASP B 37 CG OD1 OD2 REMARK 470 ARG B 47 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 49 CG CD CE NZ REMARK 470 TYR B 50 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 74 CG CD CE NZ REMARK 470 LYS B 76 CG CD CE NZ REMARK 470 VAL B 105 CG1 CG2 REMARK 470 ASN B 117 CG OD1 ND2 REMARK 470 PHE B 121 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 122 CG CD CE NZ REMARK 470 GLN B 123 CG CD OE1 NE2 REMARK 470 LEU B 124 CG CD1 CD2 REMARK 470 TYR B 125 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN B 126 CG CD OE1 NE2 REMARK 470 GLU B 167 CG CD OE1 OE2 REMARK 470 ARG B 169 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 170 CD CE NZ REMARK 470 ARG B 191 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 264 CG CD OE1 OE2 REMARK 470 ARG B 268 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 271 CG OD1 OD2 REMARK 470 ARG B 275 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 329 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 120 128.22 -38.18 REMARK 500 ASP A 156 40.22 -154.07 REMARK 500 ALA A 193 161.16 79.81 REMARK 500 MET A 208 54.07 -90.73 REMARK 500 HIS A 234 77.46 -101.27 REMARK 500 ARG B 107 16.38 50.89 REMARK 500 PHE B 121 53.04 -90.83 REMARK 500 THR B 127 14.07 -144.91 REMARK 500 ASP B 156 43.48 -148.53 REMARK 500 ALA B 193 157.58 82.84 REMARK 500 MET B 208 53.21 -90.58 REMARK 500 HIS B 234 76.07 -100.79 REMARK 500 REMARK 500 REMARK: NULL DBREF 8PVP A 1 337 UNP P68400 CSK21_HUMAN 1 337 DBREF 8PVP B 1 337 UNP P68400 CSK21_HUMAN 1 337 SEQADV 8PVP SER A 0 UNP P68400 EXPRESSION TAG SEQADV 8PVP SER B 0 UNP P68400 EXPRESSION TAG SEQRES 1 A 338 SER MET SER GLY PRO VAL PRO SER ARG ALA ARG VAL TYR SEQRES 2 A 338 THR ASP VAL ASN THR HIS ARG PRO ARG GLU TYR TRP ASP SEQRES 3 A 338 TYR GLU SER HIS VAL VAL GLU TRP GLY ASN GLN ASP ASP SEQRES 4 A 338 TYR GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SER SEQRES 5 A 338 GLU VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU LYS SEQRES 6 A 338 VAL VAL VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS LYS SEQRES 7 A 338 ILE LYS ARG GLU ILE LYS ILE LEU GLU ASN LEU ARG GLY SEQRES 8 A 338 GLY PRO ASN ILE ILE THR LEU ALA ASP ILE VAL LYS ASP SEQRES 9 A 338 PRO VAL SER ARG THR PRO ALA LEU VAL PHE GLU HIS VAL SEQRES 10 A 338 ASN ASN THR ASP PHE LYS GLN LEU TYR GLN THR LEU THR SEQRES 11 A 338 ASP TYR ASP ILE ARG PHE TYR MET TYR GLU ILE LEU LYS SEQRES 12 A 338 ALA LEU ASP TYR CYS HIS SER MET GLY ILE MET HIS ARG SEQRES 13 A 338 ASP VAL LYS PRO HIS ASN VAL MET ILE ASP HIS GLU HIS SEQRES 14 A 338 ARG LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU PHE SEQRES 15 A 338 TYR HIS PRO GLY GLN GLU TYR ASN VAL ARG VAL ALA SER SEQRES 16 A 338 ARG TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR GLN SEQRES 17 A 338 MET TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY CYS SEQRES 18 A 338 MET LEU ALA SER MET ILE PHE ARG LYS GLU PRO PHE PHE SEQRES 19 A 338 HIS GLY HIS ASP ASN TYR ASP GLN LEU VAL ARG ILE ALA SEQRES 20 A 338 LYS VAL LEU GLY THR GLU ASP LEU TYR ASP TYR ILE ASP SEQRES 21 A 338 LYS TYR ASN ILE GLU LEU ASP PRO ARG PHE ASN ASP ILE SEQRES 22 A 338 LEU GLY ARG HIS SER ARG LYS ARG TRP GLU ARG PHE VAL SEQRES 23 A 338 HIS SER GLU ASN GLN HIS LEU VAL SER PRO GLU ALA LEU SEQRES 24 A 338 ASP PHE LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SER SEQRES 25 A 338 ARG LEU THR ALA ARG GLU ALA MET GLU HIS PRO TYR PHE SEQRES 26 A 338 TYR THR VAL VAL LYS ASP GLN ALA ARG MET GLY SER SER SEQRES 1 B 338 SER MET SER GLY PRO VAL PRO SER ARG ALA ARG VAL TYR SEQRES 2 B 338 THR ASP VAL ASN THR HIS ARG PRO ARG GLU TYR TRP ASP SEQRES 3 B 338 TYR GLU SER HIS VAL VAL GLU TRP GLY ASN GLN ASP ASP SEQRES 4 B 338 TYR GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SER SEQRES 5 B 338 GLU VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU LYS SEQRES 6 B 338 VAL VAL VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS LYS SEQRES 7 B 338 ILE LYS ARG GLU ILE LYS ILE LEU GLU ASN LEU ARG GLY SEQRES 8 B 338 GLY PRO ASN ILE ILE THR LEU ALA ASP ILE VAL LYS ASP SEQRES 9 B 338 PRO VAL SER ARG THR PRO ALA LEU VAL PHE GLU HIS VAL SEQRES 10 B 338 ASN ASN THR ASP PHE LYS GLN LEU TYR GLN THR LEU THR SEQRES 11 B 338 ASP TYR ASP ILE ARG PHE TYR MET TYR GLU ILE LEU LYS SEQRES 12 B 338 ALA LEU ASP TYR CYS HIS SER MET GLY ILE MET HIS ARG SEQRES 13 B 338 ASP VAL LYS PRO HIS ASN VAL MET ILE ASP HIS GLU HIS SEQRES 14 B 338 ARG LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU PHE SEQRES 15 B 338 TYR HIS PRO GLY GLN GLU TYR ASN VAL ARG VAL ALA SER SEQRES 16 B 338 ARG TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR GLN SEQRES 17 B 338 MET TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY CYS SEQRES 18 B 338 MET LEU ALA SER MET ILE PHE ARG LYS GLU PRO PHE PHE SEQRES 19 B 338 HIS GLY HIS ASP ASN TYR ASP GLN LEU VAL ARG ILE ALA SEQRES 20 B 338 LYS VAL LEU GLY THR GLU ASP LEU TYR ASP TYR ILE ASP SEQRES 21 B 338 LYS TYR ASN ILE GLU LEU ASP PRO ARG PHE ASN ASP ILE SEQRES 22 B 338 LEU GLY ARG HIS SER ARG LYS ARG TRP GLU ARG PHE VAL SEQRES 23 B 338 HIS SER GLU ASN GLN HIS LEU VAL SER PRO GLU ALA LEU SEQRES 24 B 338 ASP PHE LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SER SEQRES 25 B 338 ARG LEU THR ALA ARG GLU ALA MET GLU HIS PRO TYR PHE SEQRES 26 B 338 TYR THR VAL VAL LYS ASP GLN ALA ARG MET GLY SER SER HET FWU A 401 34 HET SO4 A 402 5 HET SO4 A 403 5 HET SO4 A 404 5 HET SO4 A 405 5 HET SO4 A 406 5 HET SO4 A 407 5 HET FWU B 401 34 HET SO4 B 402 5 HET SO4 B 403 5 HET SO4 B 404 5 HET SO4 B 405 5 HET SO4 B 406 5 HET SO4 B 407 5 HET SO4 B 408 5 HETNAM FWU ~{N}-[5-[(3-CHLORANYL-4-PHENYL-PHENYL) HETNAM 2 FWU METHYLAMINO]PENTYL]ISOQUINOLINE-5-SULFONAMIDE HETNAM SO4 SULFATE ION FORMUL 3 FWU 2(C27 H28 CL N3 O2 S) FORMUL 4 SO4 13(O4 S 2-) FORMUL 18 HOH *30(H2 O) HELIX 1 AA1 PRO A 20 ASP A 25 1 6 HELIX 2 AA2 TYR A 26 HIS A 29 5 4 HELIX 3 AA3 LYS A 74 ARG A 89 1 16 HELIX 4 AA4 ASP A 120 TYR A 125 1 6 HELIX 5 AA5 THR A 129 MET A 150 1 22 HELIX 6 AA6 LYS A 158 HIS A 160 5 3 HELIX 7 AA7 HIS A 166 ARG A 169 5 4 HELIX 8 AA8 ASP A 175 ALA A 179 5 5 HELIX 9 AA9 SER A 194 LYS A 198 5 5 HELIX 10 AB1 GLY A 199 VAL A 204 1 6 HELIX 11 AB2 TYR A 211 ARG A 228 1 18 HELIX 12 AB3 ASP A 237 GLY A 250 1 14 HELIX 13 AB4 GLY A 250 ASN A 262 1 13 HELIX 14 AB5 ASP A 266 LEU A 273 1 8 HELIX 15 AB6 ARG A 280 VAL A 285 5 6 HELIX 16 AB7 ASN A 289 VAL A 293 5 5 HELIX 17 AB8 SER A 294 LEU A 305 1 12 HELIX 18 AB9 ASP A 308 ARG A 312 5 5 HELIX 19 AC1 THR A 314 GLU A 320 1 7 HELIX 20 AC2 HIS A 321 TYR A 323 5 3 HELIX 21 AC3 PHE A 324 GLN A 331 1 8 HELIX 22 AC4 PRO B 20 ASP B 25 1 6 HELIX 23 AC5 TYR B 26 HIS B 29 5 4 HELIX 24 AC6 LYS B 74 ARG B 89 1 16 HELIX 25 AC7 THR B 129 MET B 150 1 22 HELIX 26 AC8 LYS B 158 HIS B 160 5 3 HELIX 27 AC9 HIS B 166 ARG B 169 5 4 HELIX 28 AD1 ASP B 175 ALA B 179 5 5 HELIX 29 AD2 SER B 194 LYS B 198 5 5 HELIX 30 AD3 GLY B 199 VAL B 204 1 6 HELIX 31 AD4 TYR B 211 ARG B 228 1 18 HELIX 32 AD5 ASP B 237 GLY B 250 1 14 HELIX 33 AD6 GLY B 250 ASN B 262 1 13 HELIX 34 AD7 PRO B 267 GLY B 274 1 8 HELIX 35 AD8 ARG B 280 VAL B 285 5 6 HELIX 36 AD9 ASN B 289 VAL B 293 5 5 HELIX 37 AE1 SER B 294 LEU B 305 1 12 HELIX 38 AE2 ASP B 308 ARG B 312 5 5 HELIX 39 AE3 THR B 314 GLU B 320 1 7 HELIX 40 AE4 HIS B 321 TYR B 323 5 3 HELIX 41 AE5 PHE B 324 GLN B 331 1 8 SHEET 1 AA1 6 GLY A 34 ASN A 35 0 SHEET 2 AA1 6 LEU A 97 LYS A 102 1 O ILE A 100 N GLY A 34 SHEET 3 AA1 6 PRO A 109 GLU A 114 -1 O VAL A 112 N ASP A 99 SHEET 4 AA1 6 GLU A 63 LEU A 70 -1 N VAL A 66 O PHE A 113 SHEET 5 AA1 6 SER A 51 ASN A 58 -1 N ASN A 58 O GLU A 63 SHEET 6 AA1 6 TYR A 39 ARG A 47 -1 N LEU A 45 O VAL A 53 SHEET 1 AA2 2 ILE A 152 MET A 153 0 SHEET 2 AA2 2 GLU A 180 PHE A 181 -1 O GLU A 180 N MET A 153 SHEET 1 AA3 2 VAL A 162 ASP A 165 0 SHEET 2 AA3 2 LYS A 170 LEU A 173 -1 O ARG A 172 N MET A 163 SHEET 1 AA4 6 GLY B 34 ASN B 35 0 SHEET 2 AA4 6 LEU B 97 LYS B 102 1 O ILE B 100 N GLY B 34 SHEET 3 AA4 6 PRO B 109 GLU B 114 -1 O VAL B 112 N ASP B 99 SHEET 4 AA4 6 GLU B 63 LEU B 70 -1 N VAL B 66 O PHE B 113 SHEET 5 AA4 6 SER B 51 ASN B 58 -1 N ASN B 58 O GLU B 63 SHEET 6 AA4 6 TYR B 39 ARG B 47 -1 N LEU B 45 O VAL B 53 SHEET 1 AA5 2 ILE B 152 MET B 153 0 SHEET 2 AA5 2 GLU B 180 PHE B 181 -1 O GLU B 180 N MET B 153 SHEET 1 AA6 2 VAL B 162 ASP B 165 0 SHEET 2 AA6 2 LYS B 170 LEU B 173 -1 O ARG B 172 N MET B 163 CISPEP 1 GLU A 230 PRO A 231 0 -6.27 CISPEP 2 GLU B 230 PRO B 231 0 -4.24 CRYST1 127.009 127.009 125.838 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007873 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007873 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007947 0.00000